Hrustanovic Gorjan 4
4 · Kymera Therapeutics, Inc. · Filed Aug 21, 2020
Insider Transaction Report
Form 4
Hrustanovic Gorjan
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-08-20+40,127→ 40,127 totalExercise: $20.00Exp: 2030-08-19→ Common Stock (40,127 underlying)
Footnotes (2)
- [F1]The shares subject to this option shall vest in thirty-six (36) equal monthly installments over three (3) years commencing on the date of the Registration Statement Effectiveness.
- [F2]The reporting person is a member of BVF Partners L.P. ("BVF") and is obligated to transfer the economic benefit, if any, received upon the sale of the shares issuable upon exercise of the equity grants to BVF. As such, the Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein, if any.